Sema Sevimli

1.1k citations
12 papers · 1k · 1 hit paper · h-index 11

Impact in

  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • interferon and immune responses
    • Nanoparticle-Based Drug Delivery

Papers in

    • Nanoparticle-Based Drug Delivery 4
    • Immunotherapy and Immune Responses 5
    • interferon and immune responses 1

Sema Sevimli

12 papers receiving 1k citations

Sema Sevimli's Hit Papers

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy 2019 · 598 citations
5980+2+4Years since publication100200300400500

Peers

Sema Sevimli
Comparison fields: 5 of 48
  • Immunology 483
  • Biomaterials 278
  • Drug Discovery 2
  • Pharmaceutical Science 48
  • Oncology 144
Replace Lauren E. Milling with:
Lauren E. Milling United States
Clara Park United States
Coralie M. Backlund United States
Xiaobo Xi China
Hathaichanok Phuengkham United States
Min Luo China
Sachin H. Bhagchandani United States
Lien Lybaert Belgium
Laura Jeanbart United States
Qingle Song China
Sema Sevimli relative to Lauren E. Milling United States Lauren E. Milling's profile →
Citations per field
00.5×1.5×2.2×
Lauren E. Milling · 1×
Citations per year

Countries citing papers authored by Sema Sevimli

Since Specialization
Citations

This map shows the geographic impact of Sema Sevimli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sema Sevimli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sema Sevimli more than expected).

Fields of papers citing papers by Sema Sevimli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sema Sevimli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sema Sevimli. The network helps show where Sema Sevimli may publish in the future.

Co-authors

The 25 scholars most cited alongside Sema Sevimli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sema Sevimli Line = papers co-authored together Sema Sevimli links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Hit paper breakdown →
2019598
2 2019124
3 201880
4 201242
5 201040
6 201231
7 201628
8 201424
9 202124
10 201315
11 201912
12 20137

About Sema Sevimli

Sema Sevimli is a scholar working on Biomaterials, Immunology, Organic Chemistry, Molecular Biology and Biomedical Engineering, having authored 12 papers that have together received 1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Advanced Polymer Synthesis and Characterization (4 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers), Lipid Membrane Structure and Behavior (1 paper), Nanoplatforms for cancer theranostics (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Immunology (483 citations), Biomaterials (278 citations), Drug Discovery (2 citations), Pharmaceutical Science (48 citations) and Oncology (144 citations). Sema Sevimli has collaborated with scholars based in Australia, United States and Türkiye. Frequent co-authors include John T. Wilson, Kyle W. Becker, Daniel Shae, Manuel Ascano, Justin Micah Balko, Mark C. Kelley, Douglas Buckner Johnson, Plamen P. Christov, Abigail K. R. Lytton‐Jean and Dong Soo Yun. Their work appears in journals such as Biomacromolecules, Frontiers in Immunology, Macromolecules, ACS Biomaterials Science & Engineering and European Polymer Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact